1921
Volume 103, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Parasite resistance to antimalarial drugs poses a serious threat to malaria control. The WorldWide Antimalarial Resistance Network (WWARN) aims to provide a collaborative platform to support the global malaria research effort. Here, we describe the “WWARN clinical trials publication library,” an open-access, up-to-date resource to streamline the synthesis of antimalarial safety and efficacy data. A series of iteratively refined database searches were conducted to identify prospective clinical trials assessing antimalarial drug efficacy with at least 28 days of follow-up. Of approximately 45,000 articles screened, 1,221 trials published between 1946 and 2018 were identified, representing 2,339 treatment arms and 323,819 patients. In trials from endemic locations, 75.7% (787/1,040) recruited patients with , 17.0% (177/1,040) , 6.9% (72/1,040) both, and 0.4% (4/1,040) other species; 57.2% (585/1,022) of trials included under-fives and 5.3% (55/1,036) included pregnant women. In Africa, there has been a marked increase in both and studies over the last two decades. The WHO-recommended artemisinin-based combination therapies alone or with a gametocidal drug were assessed in 39.5% (705/1,783) of treatment arms and 10.5% (45/429) of arms, increasing to 78.0% (266/341) and 22.9% (27/118), respectively, in the last five years. The library is a comprehensive, open-access tool that can be used by the malaria community to explore the collective knowledge on antimalarial efficacy (available at https://www.wwarn.org/tools-resources/literature-reviews/wwarn-clinical-trials-publication-library). It is the first of its kind in the field of global infectious diseases, and lessons learnt in its creation can be adapted to other infectious diseases.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0706
2020-05-18
2020-09-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/103/1/tpmd190706.html?itemId=/content/journals/10.4269/ajtmh.19-0706&mimeType=html&fmt=ahah

References

  1. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga P, Lim S, Suon S, Anderson JM, 2014. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371: 411423.
    [Google Scholar]
  2. Commons RJ, Thriemer K, Humphreys G, Suay I, Sibley CH, Guerin PJ, Price RN, 2017. The vivax surveyor: online mapping database for Plasmodium vivax clinical trials. Int J Parasitol Drugs Drug Resist 7: 181190.
    [Google Scholar]
  3. Price RN, Seidlein von L, Valecha N, Nosten F, Baird KJ, White NJ, 2014. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis 14: 982991.
    [Google Scholar]
  4. John G, Douglas NM, Seidlein von L, Nosten F, Baird KJ, White NJ, Price RN, 2012. Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J 11: 280.
    [Google Scholar]
  5. Commons RJ, Simpson JA, Thriemer K, Hossain MS, Douglas NM, Humphreys GS, Sibley CH, Guerin PJ, Price RN, 2018. Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis. Lancet Infect Dis 19: 91101.
    [Google Scholar]
  6. WorldWide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group, 2015. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data. Lancet Infect Dis 15: 692702.
    [Google Scholar]
  7. The WorldWide Antimalarial Resistance Network (WWARN), 2015. The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med 13: S8S19.
    [Google Scholar]
  8. The WorldWide Antimalarial Resistance Network (WWARN) DP Study Group, 2013. The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data. PLos Med 10: e1001564.
    [Google Scholar]
  9. Das D, Price RN, Bethell D, Guerin PJ, Stepniewska K, 2013. Early parasitological response following artemisinin-containing regimens: a critical review of the literature. Malar J 12: 113.
    [Google Scholar]
  10. WWARN Clinical Trials Publication Library, 2020. Available at: https://www.wwarn.org/tools-resources/literature-reviews/wwarn-clinical-trials-publication-library. Accessed April 7, 2020.
  11. World Health Organization, 2009. Methods for Surveillance of Antimalarial Drug Efficacy. Geneva, Switzerland: WHO Press.
    [Google Scholar]
  12. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, 2009. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42: 377381.
    [Google Scholar]
  13. Harris PA et al., The REDCap Consortium, 2019. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95: 103208.
    [Google Scholar]
  14. United Nations, 1970. Standard Country or Area Codes for Statistical Use (M49). Available at: https://unstats.un.org/unsd/methodology/m49/overview/. Accessed July 31, 2019.
    [Google Scholar]
  15. World Health Organization, 2019. World Malaria Report 2019. Geneva, Switzerland: World Health Organization. 1232.
    [Google Scholar]
  16. The WorldWide Antimalarial Resistance Network (WWARN), 2016. The Vivax Surveyor. Available at: https://www.wwarn.org/tracking-resistance/vivax-surveyor. Accessed July 31, 2019.
    [Google Scholar]
  17. Saito M, Gilder ME, Nosten F, McGready R, Guérin PJ, 2017. Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges. Malar J 16: 488.
    [Google Scholar]
  18. Shojania KG, Sampson M, Ansari MT, Ji J, Doucette S, Moher D, 2007. How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med 147: 224233.
    [Google Scholar]
  19. World Health Organization, 2006. Bridging the “Know–Do” Gap. Available at: https://www.measureevaluation.org/resources/training/capacity-building-resources/high-impact-research-training-curricula/bridging-the-know-do-gap.pdf. Accessed July 31, 2019.
    [Google Scholar]
  20. Neville J et al., 2015. Development of a unified clinical trial database for Alzheimer’s disease. Alzheimer’s Demen 11: 12121221.
    [Google Scholar]
  21. Humphreys GS, Tinto H, Barnes KI, 2019. Strength in numbers: the WWARN case study of purpose-driven data sharing. Am J Trop Med Hyg 100: 1315.
    [Google Scholar]
  22. Elliott JH, Turner T, Clavisi O, Higgins JP, Mavergames C, Gruen RL, 2014. Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLos Med 11: 16.
    [Google Scholar]
  23. Ohmann C et al., 2017. Sharing and reuse of individual participant data from clinical trials: principles and recommendations. BMJ Open 7: e018647.
    [Google Scholar]
  24. Mello MM, Francer JK, Wilenzick M, Teden P, Bierer BE, Barnes M, 2013. Preparing for responsible sharing of clinical trial data. N Engl J Med 369: 16511658.
    [Google Scholar]
  25. Vickers A, 2016. Sharing raw data from clinical trials: what progress since we first asked “Whose data set is it anyway?” Trials 17: 227.
    [Google Scholar]
  26. Institute of Medicine, 2015. Sharing Clinical Trial Data. Washington, DC: The National Academies Press, 1304.
    [Google Scholar]
  27. De Silva S, Bailey AP, Parker AG, Montague AE, Hetrick SE, 2018. Open-access evidence database of controlled trials and systematic reviews in youth mental health. Early Interv Psychiatry 12: 474477.
    [Google Scholar]
  28. Bragge P, Clavisi O, Turner T, Tavender E, Collie A, Gruen RL, 2011. The global evidence mapping initiative: scoping research in broad topic areas. BMC Med Res Methodol 11: 92.
    [Google Scholar]
  29. Julé AM, Vaillant M, Lang TA, Guérin PJ, Olliaro PL, 2016. The schistosomiasis clinical trials landscape: a systematic review of antischistosomal treatment efficacy studies and a case for sharing individual participant-level data (IPD). PLoS Negl Trop Dis 10: e0004784.
    [Google Scholar]
  30. Halder JB, Benton J, Julé AM, Guérin PJ, Olliaro PL, Basáñez M-G, Walker M, 2017. Systematic review of studies generating individual participant data on the efficacy of drugs for treating soil-transmitted helminthiases and the case for data-sharing. PLoS Negl Trop Dis 11: e0006053.
    [Google Scholar]
  31. Bush JT, Wasunna M, Alves F, Alvar J, Olliaro PL, Otieno M, Sibley CH, Strub Wourgaft N, Guérin PJ, 2017. Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: a first step to assess the feasibility of establishing an individual patient data sharing platform. PLoS Negl Trop Dis 11: e0005781.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0706
Loading
/content/journals/10.4269/ajtmh.19-0706
Loading

Data & Media loading...

  • Received : 23 Sep 2019
  • Accepted : 14 Mar 2020
  • Published online : 18 May 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error